CompoAtlas

Bouleau Radis noir Citron

Food supplement declared in France, declaration No 2018-12-315

Bouleau Radis noir Citron (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: retiré du marché le 31 August 2025. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Laboratoires Vitarmonyl
Food business operator placing the product on the market
Laboratoires VITARMONYL
Status
Retiré du marché le 31 August 2025
Form
Ampoule
Daily dose
1 ampoule
Directions for use
à boire pure ou diluée
Not recommended for (according to the manufacturer)
Allergie aux dérivés salicylés, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Détoxifiant / Draineur

Declaration 160462, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Raphanus sativus L.RacinePression à froid5,970 mg
Betula pendula RothFeuilleExtrait sec aqueux250 mg
Citrus limon (L.) Burm. f.FruitPression à froid230 mg

Other ingredients

eau

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Betula pendula Roth
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 August 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Laboratoires Vitarmonyl

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line